(Q33385809)

26 July 2017

1 reference

title

Hemolytic uremic syndrome: pathogenesis and update of interventions (English)

1 reference

26 July 2017

Marina S Palermo

1

1 reference

26 July 2017

Ramón A Exeni

series ordinal

2

1 reference

26 July 2017

Gabriela C Fernández

series ordinal

3

1 reference

26 July 2017

publication date

1 August 2009

1 reference

Expert Review of Anti-infective Therapy

26 July 2017

published in

1 reference

26 July 2017

volume

7

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

697-707

1 reference

THE HEMOLYTIC-UREMIC SYNDROME.

26 July 2017

cites work

1 reference

Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools

21 January 2018

1 reference

Long-term course and mechanisms of progression of renal disease in hemolytic uremic syndrome

21 January 2018

1 reference

Association between severity of gastrointestinal prodrome and long-term prognosis in classic hemolytic-uremic syndrome

21 January 2018

1 reference

Childhood hemolytic uremic syndrome is associated with adolescent-onset diabetes mellitus

21 January 2018

1 reference

Relationship between Escherichia coli O157:H7 and diabetes mellitus

21 January 2018

1 reference

Variation in acid resistance among shiga toxin-producing clones of pathogenic Escherichia coli

21 January 2018

1 reference

A comparison of enteropathogenic and enterohaemorrhagic Escherichia coli pathogenesis.

21 January 2018

1 reference

Pathogenic Escherichia coli

21 January 2018

1 reference

Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis

21 January 2018

1 reference

Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells.

21 January 2018

1 reference

Cytotoxic effect of Shiga toxin-2 holotoxin and its B subunit on human renal tubular epithelial cells

21 January 2018

1 reference

Cytokine expression in the renal tubular epithelial cells stimulated by Shiga toxin 2 of Escherichia coli O157:H7.

21 January 2018

1 reference

Up-regulation of tissue factor activity on human proximal tubular epithelial cells in response to Shiga toxin

21 January 2018

1 reference

Shiga toxin-encoding bacteriophages--genomes in motion

21 January 2018

1 reference

Identification, characterization, and distribution of a Shiga toxin 1 gene variant (stx(1c)) in Escherichia coli strains isolated from humans

21 January 2018

1 reference

Identification and Characterization of a New Variant of Shiga Toxin 1 in Escherichia coli ONT:H19 of Bovine Origin

21 January 2018

1 reference

Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms

21 January 2018

1 reference

Shiga toxin 2e-producing Escherichia coli isolates from humans and pigs differ in their virulence profiles and interactions with intestinal epithelial cells

21 January 2018

1 reference

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS).

21 January 2018

1 reference

Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies

21 January 2018

1 reference

The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect

21 January 2018

1 reference

Membrane cytosolic translocation of verotoxin A1 subunit in target cells.

21 January 2018

1 reference

Verotoxin 1 binding to intestinal crypt epithelial cells results in localization to lysosomes and abrogation of toxicity.

21 January 2018

1 reference

Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1.

21 January 2018

1 reference

Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress

21 January 2018

1 reference

Verotoxin biology: molecular events in vascular endothelial injury

21 January 2018

1 reference

Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina

21 January 2018

1 reference

Continuous surveillance of Shiga toxin-producing Escherichia coli infections by pulsed-field gel electrophoresis shows that most infections are sporadic.

21 January 2018

1 reference

VTEC O157 subtypes associated with the most severe clinical symptoms in humans constitute a minor part of VTEC O157 isolates from Danish cattle.

21 January 2018

1 reference

Shiga toxin-producing Escherichia coli: an overview

21 January 2018

1 reference

Host and pathogen determinants of verocytotoxin-producing Escherichia coli-associated hemolytic uremic syndrome

21 January 2018

1 reference

Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains

21 January 2018

1 reference

Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome.

21 January 2018

1 reference

Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles

21 January 2018

1 reference

Enterohemolysin operon of Shiga toxin-producing Escherichia coli: a virulence function of inflammatory cytokine production from human monocytes.

21 January 2018

1 reference

Isolation, characterization, and epidemiological assessment of shiga toxin-producing Escherichia coli O84 isolates from New Zealand

21 January 2018

1 reference

A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli

21 January 2018

1 reference

Glycosphingolipids are not pivotal receptors for Subtilase cytotoxin in vivo: sensitivity analysis with glycosylation-defective mutant mice

21 January 2018

1 reference

Novel subtilase cytotoxin produced by Shiga-toxigenic Escherichia coli induces apoptosis in vero cells via mitochondrial membrane damage

21 January 2018

1 reference

Subtilase cytotoxin, produced by Shiga-toxigenic Escherichia coli, transiently inhibits protein synthesis of Vero cells via degradation of BiP and induces cell cycle arrest at G1 by downregulation of cyclin D1

21 January 2018

1 reference

Pathologic changes in mice induced by subtilase cytotoxin, a potent new Escherichia coli AB5 toxin that targets the endoplasmic reticulum

21 January 2018

1 reference

Cytolethal distending toxin gene cluster in enterohemorrhagic Escherichia coli O157:H- and O157:H7: characterization and evolutionary considerations

21 January 2018

1 reference

Characterization of cytolethal distending toxin genes and expression in shiga toxin-producing Escherichia coli strains of non-O157 serogroups

21 January 2018

1 reference

The StcE protease contributes to intimate adherence of enterohemorrhagic Escherichia coli O157:H7 to host cells

21 January 2018

1 reference

EspJ is a prophage-carried type III effector protein of attaching and effacing pathogens that modulates infection dynamics

21 January 2018

1 reference

A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease

21 January 2018

1 reference

Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody

21 January 2018

1 reference

Role of Shiga toxin versus H7 flagellin in enterohaemorrhagic Escherichia coli signalling of human colon epithelium in vivo.

21 January 2018

1 reference

Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration

21 January 2018

1 reference

Human neutrophils and their products induce Shiga toxin production by enterohemorrhagic Escherichia coli

21 January 2018

1 reference

Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome

21 January 2018

1 reference

Impaired neutrophils in children with the typical form of hemolytic uremic syndrome

21 January 2018

1 reference

Phenotype markers and function of neutrophils in children with hemolytic uremic syndrome

21 January 2018

1 reference

The functional state of neutrophils correlates with the severity of renal dysfunction in children with hemolytic uremic syndrome

21 January 2018

1 reference

Hemolytic uremic syndrome in children: platelet aggregation and membrane glycoproteins

21 January 2018

1 reference

Soluble P‐selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome

21 January 2018

1 reference

Differential expression of function-related antigens on blood monocytes in children with hemolytic uremic syndrome

21 January 2018

1 reference

Involvement of the fractalkine pathway in the pathogenesis of childhood hemolytic uremic syndrome

21 January 2018

1 reference

Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002.

21 January 2018

1 reference

21 January 2018

Escherichia coli O157:H7

1 reference

Virulence genotypes and serotypes of verotoxigenic Escherichia coli isolated from cattle and foods in Argentina. Importance in public health

21 January 2018

1 reference

Shiga toxin-producing Escherichia coli in healthy young beef steers from Argentina: prevalence and virulence properties.

21 January 2018

1 reference

Isolation and characterization of Shiga toxin-producing Escherichia coli from precooked sausages (morcillas).

21 January 2018

1 reference

Shiga toxin-producing Escherichia coli O157 in beef and chicken burgers, and chicken carcasses in Buenos Aires, Argentina.

21 January 2018

1 reference

Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities

21 January 2018

1 reference

An outbreak of Escherichia coli O157:H7 infections among visitors to a dairy farm

21 January 2018

1 reference

All blood, no stool: enterohemorrhagic Escherichia coli O157:H7 infection

21 January 2018

1 reference

Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion

21 January 2018

1 reference

Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy

21 January 2018

1 reference

Hemolytic uremic syndrome; pathogenesis, treatment, and outcome

21 January 2018

1 reference

E. coli, antibiotics, and the hemolytic-uremic syndrome

21 January 2018

1 reference

Management of diarrhea-associated hemolytic uremic syndrome in children

21 January 2018

1 reference

Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis

21 January 2018

1 reference

The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections

21 January 2018

1 reference

New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome

21 January 2018

1 reference

Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials

21 January 2018

1 reference

Steroids in the hemolytic uremic syndrome

21 January 2018

1 reference

Low levels of serum erythropoietin in children with endemic hemolytic uremic syndrome

21 January 2018

1 reference

Early erythropoietin reduced the need for red blood cell transfusion in childhood hemolytic uremic syndrome: a randomized prospective pilot trial

21 January 2018

1 reference

Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology

21 January 2018

1 reference

Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial

21 January 2018

1 reference

Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections

21 January 2018

1 reference

Long-term follow-up of Argentinean patients with hemolytic uremic syndrome who had not undergone dialysis

21 January 2018

1 reference

Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial

21 January 2018

1 reference

Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.

21 January 2018

1 reference

Neutralization of Shiga toxins Stx1, Stx2c, and Stx2e by recombinant bacteria expressing mimics of globotriose and globotetraose

21 January 2018

1 reference

Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands

21 January 2018

1 reference

A multivalent peptide library approach identifies a novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin

21 January 2018

1 reference

Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection

21 January 2018

1 reference

Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variants

21 January 2018

1 reference

The 13C4 monoclonal antibody that neutralizes Shiga toxin Type 1 (Stx1) recognizes three regions on the Stx1 B subunit and prevents Stx1 from binding to its eukaryotic receptor globotriaosylceramide

21 January 2018

1 reference

Intracellular neutralization of shiga toxin 2 by an a subunit-specific human monoclonal antibody

21 January 2018

1 reference

Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome

21 January 2018

1 reference

Escherichia coli O157:H7 infections: discordance between filterable fecal shiga toxin and disease outcome

21 January 2018

1 reference

Chlorine inactivation of Escherichia coli O157:H7.

21 January 2018

1 reference

Application of bacteriophages to control intestinal Escherichia coli O157:H7 levels in ruminants

21 January 2018

1 reference

Current progress in enteropathogenic and enterohemorrhagic Escherichia coli vaccines

21 January 2018

1 reference

Safety and immunogenicity of Escherichia coli O157 O-specific polysaccharide conjugate vaccine in 2-5-year-old children

21 January 2018

1 reference

The hemolytic uremic syndrome

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERI.09.49

1 reference

26 July 2017

1 reference